You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

SODIUM NITROPRUSSIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for sodium nitroprusside and what is the scope of freedom to operate?

Sodium nitroprusside is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Vpna, Abraxis Pharm, Amneal, Amphastar Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Be Pharms, Caplin, Chartwell Rx, Cipla, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Hainan Poly Pharm, Micro Labs, Mylan Labs Ltd, Nexus, Norvium Bioscience, Sagent Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Xiromed, Exela Pharma, and Hainan Poly, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for sodium nitroprusside. Sixteen suppliers are listed for this compound.

Summary for SODIUM NITROPRUSSIDE
Drug Prices for SODIUM NITROPRUSSIDE

See drug prices for SODIUM NITROPRUSSIDE

Recent Clinical Trials for SODIUM NITROPRUSSIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EgymedicalpediaEarly Phase 1
Tanta UniversityN/A
Kafrelsheikh UniversityN/A

See all SODIUM NITROPRUSSIDE clinical trials

Pharmacology for SODIUM NITROPRUSSIDE
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for SODIUM NITROPRUSSIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 210855-001 Jul 16, 2018 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 208635-001 May 4, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hainan Poly SODIUM NITROPRUSSIDE sodium nitroprusside SOLUTION;INTRAVENOUS 215846-003 Aug 26, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sagent Pharms Inc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 207426-001 Dec 8, 2016 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Avet Lifesciences SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 208923-001 Nov 8, 2022 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Parenteral SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 073465-001 Mar 30, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.